Keyphrases
Therapeutic Target
100%
Wilms Tumor
100%
Tumor Antigen
100%
ErbB2
100%
Tumor Xenograft
30%
Monoclonal Antibody
23%
Chemotherapy
23%
Radiotherapy
15%
Tumor Therapeutics
15%
Treatment Burden
15%
Novel Therapeutics
7%
Systemic Administration
7%
Intraperitoneal Injection
7%
Therapeutic Approaches
7%
Breast Cancer
7%
Tumor
7%
Positive Control
7%
Tumor Cells
7%
Current Treatment
7%
Nude Mice
7%
Xenograft
7%
Cure Rate
7%
In Vivo Model
7%
Tumor Metastasis
7%
Growth Hormone Receptor
7%
Immunostaining
7%
High Stage
7%
Secondary Malignancy
7%
Neutropenic Sepsis
7%
Fluorescence-activated Cell Sorter
7%
In Vivo Xenograft Model
7%
Multimodality
7%
Paraffin Embedding
7%
Tumor Stage
7%
Anaplastic
7%
Growth Retardation
7%
Early Complications
7%
Late Complications
7%
Medicine and Dentistry
Wilms' Tumor
100%
Tumor Antigen
100%
Tumor Xenograft
30%
Monoclonal Antibody
23%
Disease
15%
Xenograft
15%
Neoplasm
15%
Radiation Therapy
15%
Systemic Administration
7%
Fluorescence Activated Cell Sorting
7%
Tumor Cell
7%
Breast Cancer
7%
Metastatic Carcinoma
7%
Immunohistochemistry
7%
Cancer
7%
Intraperitoneal Drug Administration
7%
Sepsis
7%
Growth Retardation
7%
Cancer Staging
7%
Growth Factor Receptor
7%
Pharmacology, Toxicology and Pharmaceutical Science
Nephroblastoma
100%
Tumor Antigen
100%
Chemotherapy
23%
Monoclonal Antibody
23%
Disease
15%
Neoplasm
15%
Intraperitoneal Injection
7%
Systemic Administration
7%
Breast Cancer
7%
Fluorescence Activated Cell Sorting
7%
Growth Factor Receptor
7%
Growth Retardation
7%
Metastasis
7%
Nude Mouse
7%
Cancer Staging
7%
Sepsis
7%